55
Views
15
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Absence of SLC22A12 gene mutations in Greek Caucasian patients with primary renal hypouricaemia

, , , , &
Pages 589-595 | Received 03 Nov 2006, Accepted 15 Dec 2006, Published online: 08 Jul 2009
 

Abstract

Objective. Primary renal hypouricaemia is a hereditary clinical disorder characterized by increased renal urate clearance due to isolated renal tubular defect of uric acid transport. There have been only a few studies on primary renal hypouricaemia in Caucasian populations. Defects in the SLC22A12 gene, which encodes the renal urate transporter URAT1, have been reported to be related to the disease pathogenesis. This study was undertaken to elucidate whether SLC22A12 gene mutations are responsible for low serum uric acid levels in Greek people. Material and methods. Nine Greek Caucasian subjects with primary renal hypouricaemia were included in the study. All had serum uric acid less than 2.5 mg dL−1 (0.14 mmol L−1), fractional excretion of uric acid more than 10 % and no other known causes of hypouricaemia. Mutation analysis of the SLC22A12 gene was performed. Results. No mutation was found – only the previously reported silent polymorphism 1246T>C (His142His) in exon 2 of the SLC22A12 gene. Conclusions. No previously reported mutation of URAT1 was associated with primary renal hypouricaemia in Greek subjects.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.